Pharma Solutions

Lantheus Pharma Solutions works side by side with pharmaceutical and academic sponsors to deliver radiodiagnostic imaging agents. Our solutions help build confidence by turning scientific ambition into pursuit of progress.

Helping to empower our global partners

Lantheus is the trusted global partner for investigational radiodiagnostic imaging agents that help to empower clinical trials in oncology, neurology and cardiology. Backed by our decades of experience, established infrastructure and global distribution network, we help ensure the right dose reaches the right site at the right time, consistently and compliantly.

pharma and academic clinical trials supported globally1

Clinical trial support enabled by a manufacturing network across North America, Europe and Asia

A trusted partner across key therapeutic areas

Leveraging deep expertise in PET radiodiagnostics, we seek to enable clinical trial execution from early development through late‑stage programs with our portfolio of investigational radiodiagnostic imaging agents.

Oncology

Neurology

Cardiology

Lantheus has an investigational portfolio of oncology imaging agents. As part of the Pharma Solutions offering, we provide these investigational imaging agents to our partners to assist in the characterization of disease biology, identification and enrollment of patients in clinical trials, and assessment of treatment response during development.

Lantheus has an investigational portfolio of PET radiodiagnostic imaging agents in neurodegenerative disease, including tau- and beta-amyloid-targeting candidates under clinical evaluation. As part of the Pharma Solutions offering, we provide these investigational imaging agents to our partners to identify patients for potential therapies, assessment of biological effects and evaluation of disease progression.

Lantheus is developing investigational PET radiodiagnostic imaging agents in cardiovascular diseases, including candidates that target amyloid deposits that may be present in the heart. As part of the Pharma Solutions offering, we provide these investigational imaging agents to our partners to support potential characterization of disease biology and evaluation of therapeutic activity and disease progression in clinical trials.

See our pipeline

Partnership capabilities

From global supply and site readiness to manufacturing quality, regulatory and hands-on operational support, Lantheus Pharma Solutions delivers the capabilities sponsors need to integrate Lantheus’ investigational radiodiagnostic imaging agents, supporting the advancement of clinical studies with confidence and speed.

Global distribution

Leveraging our global network, we orchestrate production capacity, regional import pathways, cold‑chain integrity and contingency supply—ensuring reliable, compliant delivery of our investigational radiodiagnostic imaging agents aligned to patient‑level dosing schedules.

Site enablement

We streamline site readiness through site supply feasibility mapping, aligning identification workflows and verifying radiation safety requirements and radiopharmacy operations.

Manufacturing quality & regulatory

Our partnerships with Good Manufacturing Practice (GMP) facilities and disciplined processes ensure harmonized documentation, proper deviation/out-of-specification (OOS) handling, stability and change control. Our regulatory and pharmacovigilance teams provide guidance on safety oversight and health authority submissions for use of Lantheus diagnostic tools.

Operational excellence

Backed by a highly experienced, hands-on team with deep R&D expertise, we provide end-to-end support at every step, ensuring our partners receive the operational excellence and responsive support required to accelerate clinical development.

Partnering for success

Case study

Download

Case study

Download

Case study

Download

Case study

Download

Contact us

Required fields denoted by an asterisk (*).

Name(Required)

REFERENCES
1. Data on file as of May 2026.

Explore more of our science

Pipeline

Our investigational products are bringing our latest innovations to life.

Neurology

We’re advancing dementia care with a focus on earlier detection.

Oncology

Radiopharmaceuticals play an integral role in cancer care.